BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

479 related articles for article (PubMed ID: 30391106)

  • 1. Stereotactic body radiotherapy with adjuvant systemic therapy for early-stage non-small cell lung carcinoma: A multi-institutional analysis.
    Kann BH; Miccio JA; Stahl JM; Ross R; Verma V; Dosoretz AP; Park HS; Shafman TD; Gross CP; Yu JB; Decker RH
    Radiother Oncol; 2019 Mar; 132():188-196. PubMed ID: 30391106
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Multi-institutional analysis of stereotactic body radiation therapy for operable early-stage non-small cell lung carcinoma.
    Kann BH; Verma V; Stahl JM; Ross R; Dosoretz AP; Shafman TD; Gross CP; Park HS; Yu JB; Decker RH
    Radiother Oncol; 2019 May; 134():44-49. PubMed ID: 31005223
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comparison of Long-term Survival of Patients With Early-Stage Non-Small Cell Lung Cancer After Surgery vs Stereotactic Body Radiotherapy.
    Chi A; Fang W; Sun Y; Wen S
    JAMA Netw Open; 2019 Nov; 2(11):e1915724. PubMed ID: 31747032
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Clinical Outcomes Following Stereotactic Body Radiation Therapy (SBRT) for Stage I Medically Inoperable Small Cell Lung Carcinoma: A Multi-Institutional Analysis From the RSSearch Patient Registry.
    Singh R; Ansinelli H; Sharma D; Jenkins J; Davis J; Vargo JA; Sharma S
    Am J Clin Oncol; 2019 Jul; 42(7):602-606. PubMed ID: 31232723
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Adjuvant chemotherapy following stereotactic body radiotherapy for early stage non-small-cell lung cancer is associated with lower overall: A National Cancer Database Analysis.
    Foster CC; Rusthoven CG; Sher DJ; Feldman L; Pasquinelli M; Spiotto MT; Koshy M
    Lung Cancer; 2019 Apr; 130():162-168. PubMed ID: 30885339
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Stereotactic body radiation therapy (SBRT) improves local control and overall survival compared to conventionally fractionated radiation for stage I non-small cell lung cancer (NSCLC).
    von Reibnitz D; Shaikh F; Wu AJ; Treharne GC; Dick-Godfrey R; Foster A; Woo KM; Shi W; Zhang Z; Din SU; Gelblum DY; Yorke ED; Rosenzweig KE; Rimner A
    Acta Oncol; 2018 Nov; 57(11):1567-1573. PubMed ID: 29873277
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Stereotactic body radiotherapy versus percutaneous local tumor ablation for early-stage non-small cell lung cancer.
    Ager BJ; Wells SM; Gruhl JD; Stoddard GJ; Tao R; Kokeny KE; Hitchcock YJ
    Lung Cancer; 2019 Dec; 138():6-12. PubMed ID: 31593894
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Stereotactic body radiation therapy versus conventionally fractionated radiation therapy for early stage non-small cell lung cancer.
    Haque W; Verma V; Polamraju P; Farach A; Butler EB; Teh BS
    Radiother Oncol; 2018 Nov; 129(2):264-269. PubMed ID: 30031630
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Histology significantly affects recurrence and survival following SBRT for early stage non-small cell lung cancer.
    Baine MJ; Verma V; Schonewolf CA; Lin C; Simone CB
    Lung Cancer; 2018 Apr; 118():20-26. PubMed ID: 29571997
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Adjuvant Systemic Therapy in Patients With Early-Stage NSCLC Treated With Stereotactic Body Radiation Therapy.
    Ernani V; Appiah AK; Marr A; Zhang C; Zhen W; Smith LM; Ganti AK
    J Thorac Oncol; 2019 Mar; 14(3):475-481. PubMed ID: 30503890
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Three- Versus Five-Fraction Regimens of Stereotactic Body Radiotherapy for Peripheral Early-Stage Non-Small-Cell Lung Cancer: A Two-Institution Propensity Score-Matched Analysis.
    Ma SJ; Cummings M; Serra LM; Syed YA; Hermann GM; Chen Y; Milano MT; Singh AK; Gomez-Suescun JA; Singh DP
    Clin Lung Cancer; 2018 May; 19(3):e297-e302. PubMed ID: 29254649
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prior Treatment for Non-small Cell Lung Cancer Is Associated With Improved Survival in Patients who Undergo Definitive Stereotactic Body Radiation Therapy for a Subsequent Lung Malignancy: A Retrospective Multivariate and Matched Pair Analysis.
    Farrugia MK; Jun Ma S; Hennon MW; Nwogu CE; Dexter EU; Picone AL; Demmy TL; Gomez-Suescun JA; Fung-Kee-Fung S; Yendamuri SS; Singh AK
    Am J Clin Oncol; 2021 Jan; 44(1):18-23. PubMed ID: 33264123
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Stereotactic body radiotherapy improves the survival of patients with oligometastatic non-small cell lung cancer.
    Ouyang W; Yu J; Nuerjiang S; Li Z; Wang D; Wang X; Zhang J; Xie C
    Cancer Med; 2019 Aug; 8(10):4605-4614. PubMed ID: 31245933
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Dose-individualized stereotactic body radiotherapy for T1-3N0 non-small cell lung cancer: long-term results and efficacy of adjuvant chemotherapy.
    Chen Y; Guo W; Lu Y; Zou B
    Radiother Oncol; 2008 Sep; 88(3):351-8. PubMed ID: 18722684
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Surgery versus stereotactic body radiotherapy for clinical stage I non-small-cell lung cancer: propensity score-matching analysis including the ratio of ground glass nodules.
    Tomita N; Okuda K; Osaga S; Miyakawa A; Nakanishi R; Shibamoto Y
    Clin Transl Oncol; 2021 Mar; 23(3):638-647. PubMed ID: 32705493
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Outcomes in stage I non-small cell lung cancer following the introduction of stereotactic body radiotherapy in Alberta - A population-based study.
    Liu HW; Gabos Z; Ghosh S; Roberts B; Lau H; Kerba M
    Radiother Oncol; 2015 Oct; 117(1):71-6. PubMed ID: 26349589
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comparison of the outcomes of stereotactic body radiotherapy versus surgical treatment for elderly (≥70) patients with early-stage non-small cell lung cancer after propensity score matching.
    Dong B; Wang J; Zhu X; Chen Y; Xu Y; Shao K; Zheng L; Ying H; Chen M; Cao J
    Radiat Oncol; 2019 Nov; 14(1):195. PubMed ID: 31699115
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Adjuvant chemotherapy following SBRT for early stage non-small cell lung cancer (NSCLC) in older patients.
    Grinnell M; Appiah AK; Baine M; Ernani V; Marr A; Zhang C; Zhen W; Buddharaju LNR; Smith LM; Ganti AK
    J Geriatr Oncol; 2020 Sep; 11(7):1145-1153. PubMed ID: 32389520
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Response criteria in solid tumors (PERCIST/RECIST) and SUV
    Pierson C; Grinchak T; Sokolovic C; Holland B; Parent T; Bowling M; Arastu H; Walker P; Ju A
    Radiat Oncol; 2018 Feb; 13(1):34. PubMed ID: 29486779
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Elderly patients undergoing SBRT for inoperable early-stage NSCLC achieve similar outcomes to younger patients.
    Mancini BR; Park HS; Harder EM; Rutter CE; Corso CD; Decker RH; Husain ZA
    Lung Cancer; 2016 Jul; 97():22-7. PubMed ID: 27237023
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 24.